Thomas K. Equels, CEO, President, Executive Vice Chairman at HEMISPHERX BIOPHARMA INC (HEB), bought 40,000 shares at $0.16 ($6K) on 2016-03-11, disclosed to the SEC on 2016-03-14.
Open-market purchase of $6k HEB by CEO, President, Executive Vice Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.16 | 10,000 | $2K | 25.0% |
| 2 | $0.16 | 30,000 | $5K | 75.0% |
| Total | $0.16 avg | 40,000 | $6K | 100% |
| Filing → |
| AIM | BUY | 2020-12-17 | $25K | — | Filing → |
| AIM | BUY | 2020-09-03 | $25K | — | Filing → |
| AIM | BUY | 2020-08-21 | $25K | — | Filing → |